A porcine model for chronic hepatitis E
Ila Nimgaonkar, Alexander Ploss – 29 September 2017
Impact of hepatitis C virus eradication on hepatocellular carcinoma rates
Philippe J. Zamor, Mark W. Russo – 29 September 2017
Treatment of hepatitis C virus in advanced renal disease
Rajani Sharma, Robert S. Brown – 29 September 2017
Delta hepatitis: Toward improved diagnostics
Saleem Kamili, Jan Drobeniuc, Tonya Mixson‐Hayden, Maja Kodani – 29 September 2017
The pathological differential diagnosis of portal hypertension
Raouf E. Nakhleh – 29 September 2017
Chronic hepatitis C virus infection: Everyone should be treated
Steven Flamm – 29 September 2017
Chronic hepatitis C virus infection: Everyone should be treated
Steven Flamm – 29 September 2017
Impact of hepatitis C virus eradication on hepatocellular carcinoma rates
Philippe J. Zamor, Mark W. Russo – 29 September 2017
Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice
Qing Ou‐Yang, Xi‐Meng Lin, Yan‐Jing Zhu, Bo Zheng, Liang Li, Ying‐Cheng Yang, Guo‐Jun Hou, Xin Chen, Gui‐Juan Luo, Feng Huo, Qi‐Bin Leng, Frank J. Gonzalez, Xiao‐Qing Jiang, Hong‐Yang Wang, Lei Chen – 28 September 2017 – It is urgent that the means to improve liver regeneration (LR) be found, while mitigating the concurrent risk of hepatocarcinogenesis (HCG). Nuclear receptor corepressor 1 (NCoR1) is a co‐repressor of nuclear receptors, which regulates the expression level of metabolic genes; however, little is known about its potential contribution for LR and HCG.
Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents
Laetitia Mauge, Juliette Pavie, Dominique Batisse, Luc Darnige – 28 September 2017